141 related articles for article (PubMed ID: 31176239)
1. Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions.
Mishra P; Sharma P; Tripathi PN; Gupta SK; Srivastava P; Seth A; Tripathi A; Krishnamurthy S; Shrivastava SK
Bioorg Chem; 2019 Aug; 89():103025. PubMed ID: 31176239
[TBL] [Abstract][Full Text] [Related]
2. Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.
Tripathi PN; Srivastava P; Sharma P; Seth A; Shrivastava SK
Bioorg Med Chem; 2019 Apr; 27(7):1327-1340. PubMed ID: 30795991
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer's disease.
Srivastava P; Tripathi PN; Sharma P; Shrivastava SK
Bioorg Med Chem; 2019 Aug; 27(16):3650-3662. PubMed ID: 31288978
[TBL] [Abstract][Full Text] [Related]
5. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.
Jiang N; Ding J; Liu J; Sun X; Zhang Z; Mo Z; Li X; Yin H; Tang W; Xie SS
Bioorg Chem; 2019 Aug; 89():103027. PubMed ID: 31176237
[TBL] [Abstract][Full Text] [Related]
6. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease.
Choubey PK; Tripathi A; Tripathi MK; Seth A; Shrivastava SK
Bioorg Chem; 2021 Jun; 111():104922. PubMed ID: 33945941
[TBL] [Abstract][Full Text] [Related]
8. New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation.
Pandolfi F; De Vita D; Bortolami M; Coluccia A; Di Santo R; Costi R; Andrisano V; Alabiso F; Bergamini C; Fato R; Bartolini M; Scipione L
Eur J Med Chem; 2017 Dec; 141():197-210. PubMed ID: 29031067
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
10. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
11. Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Cao Z; Song Q; Yu G; Liu Z; Cong S; Tan Z; Deng Y
Bioorg Med Chem; 2021 Apr; 35():116074. PubMed ID: 33640707
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of derivatives of cleistopholine and their anti-acetylcholinesterase and anti-β-amyloid aggregation activity.
Wu Z; Liao W; Chen K; Qin J; Tang H
Bioorg Chem; 2018 Feb; 76():228-236. PubMed ID: 29195093
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
15. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Xu A; He F; Zhang X; Li X; Ran Y; Wei C; James Chou C; Zhang R; Wu J
Bioorg Chem; 2020 May; 98():103721. PubMed ID: 32193030
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
17. Novel Molecular Hybrids of
Sharma P; Tripathi A; Tripathi PN; Singh SS; Singh SP; Shrivastava SK
ACS Chem Neurosci; 2019 Oct; 10(10):4361-4384. PubMed ID: 31491074
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents.
El-Sayed NA; Farag AE; Ezzat MAF; Akincioglu H; Gülçin İ; Abou-Seri SM
Bioorg Chem; 2019 Dec; 93():103312. PubMed ID: 31586715
[TBL] [Abstract][Full Text] [Related]
19. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y
Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis,
Mo J; Chen T; Yang H; Guo Y; Li Q; Qiao Y; Lin H; Feng F; Liu W; Chen Y; Liu Z; Sun H
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):330-343. PubMed ID: 31856607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
